Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Primovist for Image Guided SBRT of the Liver
NCT03215355Phase 4Withdrawn
- Start
- Aug 2017
- Primary completion
- Aug 2018
- Countries
- 1
01
Overview
A Phase 4 trial of gadoxetate disodium in liver cancer. Planned start Aug 2017; status: withdrawn.
02
Drugs
gadoxetate disodium
03
Conditions
liver cancer
Beyond the preview
Go deeper on NCT03215355.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03215355.